Skip to Content
  • +49 40 3680 74990
Igloo
  • 0
  • Sign in
  • AR CS NL EN FI FR DE HI IT PL PT ES SV UK
  • Contact Us
  • Home
  • Shop
  • Support

    For user


    Support requestCustomer surveyList of all test instructions QC procedureResults evaluation

    For Test Manufacturer


    Test adaptationStep 1 | Get your Igloo Step 2 | Test calibration Step 3 | Place barcode on cartridge

    For Pharmasist


    Add to Igloo Health Map Customised Report Request
  • Downloads
  • Documents
  • For businesses

     

     For Bisnesses


    Point-of-care businesses Pharmacies Dental clinics

    Coming soon*


    Gyms and fitness centers Telemedecine Cosmetology and beauty salons Midwifery care
  • Science hub

      

    Biomarkers


    Ferritin Vitamin D TSHHbA1cLipoprotein AApolipoprotein Bhs-CRP

    Technology


    Igloo Reader Pro

    Company


    About Dx365
  • News
  • Contact us
Igloo
  • 0
    • Home
    • Shop
    • Support
    • Downloads
    • Documents
    • For businesses
    • Science hub
    • News
    • Contact us
  • +49 40 3680 74990
  • AR CS NL EN FI FR DE HI IT PL PT ES SV UK
  • Sign in
  • Contact Us

News

New tests: ApoB and Lp(a)


22 January 2025

Igloo has expanded its cardiovascular testing portfolio with the introduction of Apolipoprotein B and Lipoprotein(a) assays, enabling more detailed lipid risk assessment in point-of-care settings. Both markers can be measured using the Igloo Reader Pro and are designed for use with small blood samples, delivering results suitable for routine clinical workflows.

ApoB and Lp(a) are related but not interchangeable markers. ApoB reflects the total number of atherogenic lipoprotein particles driving atherosclerosis, while Lp(a) measures a specific ApoB-containing particle associated with inherited cardiovascular risk and additional pro-atherogenic and pro-thrombotic effects. Together, they provide complementary information that supports more comprehensive cardiovascular risk assessment.

The addition of ApoB and Lp(a) testing to traditional lipid panels supports broader cardiovascular risk stratification and aligns with growing clinical recognition of these markers in preventive care. The tests are CE-certified and suitable for integration into pharmacy and outpatient healthcare environments.

New panel: Lipids + Glucose


17 November 2025


Igloo is excited to launch its new Lipid + Glucose Panel, designed to deliver accurate, laboratory-quality results in a convenient, pharmacy-ready format.


A key factor in achieving reliable lipid and glucose measurements is maintaining precise temperature control during analysis. The Igloo Reader Pro adapter ensures this by keeping the sample at an optimal 37 °C, the ideal temperature for enzymatic reactions. This stable temperature environment guarantees high reproducibility and consistent results, comparable to those obtained in professional laboratory settings.


Using a proven enzymatic colorimetric method, the kit allows for fast testing of total cholesterol, triglycerides, HDL, and blood glucose with a small blood sample, delivering clear results in three minutes.


CE-certified and easy to integrate into everyday practice, the new Lipid + Glucose Panel empowers pharmacies and healthcare professionals to provide accessible, evidence-based preventive health monitoring.

Igloo at the Healing House event


16 November 2025


On 16 November 2025 in Berlin, Germany, the Igloo team took part in the Healing House event, where one of the guest contributors was Nina Ruge. The event brought together a wide range of perspectives on wellbeing and lifestyle, offering attendees multiple formats for exploring personal health.


Igloo Reader Pro was presented as an example of an evidence-based preventive health tool, illustrating how accessible digital solutions can support long-term wellbeing.


At Igloo, we emphasize that longevity is closely interconnected with preventive medicine. We view pharmacies as spaces centered on health, vitality, and proactive care.


The Healing House event highlighted how modern technology can help bring preventive health into everyday life and encourage a more proactive approach to wellbeing.

Health-i Award 2025


09 October 2025


Igloo Technology recognized at Health-i Awards 2025


We are excited to share that the Health-i Awards 2025 have honored the innovative rapid-test analysis device developed by the Igloo team, recognized as part of the winning project presented by goodscare.


The Igloo Reader Pro device enables precise evaluation of all common rapid tests based on test strips - with an accuracy comparable to that of medical laboratories. The Health-i jury selected it as one of this year’s most effective contributions to improving patient care.


This recognition highlights the excellence and impact of Igloo’s technology and the team’s commitment to advancing prevention and diagnostics for better healthcare outcomes.

Photo:  Marc-Steffen Unger / www.ms-unger.de info@ms-unger.de


Igloo Newsletter


08 October 2025


Introducing the Igloo Newsletter


We are thrilled to launch the Igloo Newsletter - your inside look at how our team is shaping the future of digital diagnostics.


From product developments and research insights to awards and conference participations, the newsletter will keep you up to date on everything happening at Igloo.


Stay connected, get inspired, and follow our journey as we continue to make healthcare smarter, faster, and more accessible for everyone.


Subscribe now to receive the latest updates straight to your inbox.

Thanks for registering!

Subscribe

 

New tests: ApoB and Lp(a)New panel: Lipids + GlucoseIgloo at the Healing House eventHealth-i Award 2025Igloo Newsletter
Legal

  • Imprint
  • Legal info
  • Privacy policy
  • Cookie policy
  • Sales terms and conditions


Customer Care

  • Support Request Center
  • Contact Us
  • Downloads
  • Documents
  • Test Instructions
  • Test Manufacturer Instructions
Phone support

  • +49 40 3680 74990
Social Networks

Social Media

© Dx365 GmbH - Terms & Conditions - Privacy Policy
الْعَرَبيّة | Čeština | Nederlands | English (US) | Suomi | Français | Deutsch | हिंदी | Italiano | Język polski | Português | Español | Svenska | українська
Powered by Odoo - The #1 Open Source eCommerce

Respecting your privacy is our priority.

Allow the use of cookies from this website on this browser?

We use cookies to provide improved experience on this website. You can learn more about our cookies and how we use them in our Cookie Policy.

Allow all cookies
Only allow essential cookies